Details of the Drug

General Information of Drug (ID: DMLOWQ6)

• Drug Name: PEP-CMV

Indication

Disease Entry	ICD 11	Status	REF
Malignant glioma	2A00.0	Phase 1	[1]
Medulloblastoma	2A00.10	Phase 1	[1]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: D9L2WN

References

• [1] ClinicalTrials.gov (NCT03299309) PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma (PRiME). U.S. National Institutes of Health.